Innova Biosciences , inventor of the worldâ€™s easiest to use bioconjugation kits, is pleased to announce that the company has entered into a licensing agreement with StressMarq Biosciences (British Columbia, Canada).
Online PR News – 27-September-2012 – Cambridge, UK, September 26, 2012 – Innova Biosciences (Cambridge, UK), inventor of the worldâ€™s easiest to use bioconjugation kits, is pleased to announce that the company has entered into a licensing agreement with StressMarq Biosciences (British Columbia, Canada).
The non-exclusive license will allow StressMarq to use Innovaâ€™s unique Lightning-LinkÂ® technology for commercial purposes. Through the commercialisation deal, StressMarq will create a novel collection of antibody conjugate research tools for the scientific community, with the ultimate objective being the advancement of pioneering science and to elucidate the molecular abnormalities behind disease states such as cancer or diabetes.
Dr Andy Lane, Licensing Manager at Innova Biosciences, said, â€śThis agreement underlines the attractiveness of the Lightning-LinkÂ® technology to specialist antibody companies, who can take advantage of the simplicity of the method combined with 100% yields to rapidly increase their catalogue portfolios. We look forward to working with StressMarq, who have an excellent reputation in the research antibody sector.â€ť
Commenting on the agreement StressMarqâ€™s President, Dr Ariel Louwrier, said, â€śThe unique aspects of the Lightning-LinkÂ® technology coupled with the core expertise of StressMarq Biosciences in the heat shock protein, cellular stress, ion channels and transporter areas will allow us to better serve the needs of our customers, covering a whole new host of applications. The demonstrated and proven Lightning-LinkÂ® technology is an excellent counterpart to our antibody portfolio.â€ť
About Innova Biosciences Limited;
Innova Biosciences is a growing, dynamic business based in Cambridge, UK. At the core of Innova's business are the Lightning-LinkÂ® and InnovaCoatâ„˘ technologies, which simplify the production of antibody-based reagents. The expanding Lightning-LinkÂ® and InnovaCoatâ„˘ portfolio is sold to research laboratories, pharmaceutical companies, biotechnology companies and diagnostic companies worldwide. For more information, please see www.innovabiosciences.com.
About StressMarq Biosciences;
StressMarq Biosciences Inc. is a company based in Victoria, British Columbia, Canada, and encompasses what is probably the most experienced combined commercial and scientific heat shock and cellular stress community worldwide. StressMarq Biosciences provide a range of monoclonal and polyclonal antisera, for various research areas including cellular stress, cell signaling, ion channels and apoptosis. For more information, please see www.stressmarq.com.